Showing results (861-870 of 905) with videos related to

Sort By:
Pageof 91
Journal of Medicinal Chemistry|December 5, 2017
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory DiseasesLaura Carzaniga, Gabriele Amari, Andrea Rizzi, et al.
Journal of Biomedical Science|February 19, 2025
K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunityQiuming Zeng, Hui Guo, Na Tang, et al.
International Journal of Cancer|June 6, 2025
Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacyKohei Tajima, Masahiro Hosonuma, Eiji Funayama, et al.
Microbiology Spectrum|January 16, 2025
Association between the <i>ABCC11</i> gene polymorphism-determined earwax properties and external auditory canal microbiota in healthy adultsYasunobu Amari, Masahiro Hosonuma, Takuya Mizukami, et al.
Journal of Medicinal Chemistry|August 10, 2023
Optimization of M<sub>3</sub> Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPDAndrea Rizzi, Gabriele Amari, Fausto Pivetti, et al.
Nature Communications|June 1, 2023
Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient miceAvinash K Persaud, Matthew C Bernier, Michael A Massey, et al.
Cell Death Discovery|April 13, 2025
An in vivo "turning model" reveals new RanBP9 interactions in lung macrophagesYasuko Kajimura, Shuxin Dong, Anna Tessari, et al.
Journal of Medicinal Chemistry|June 18, 2021
Discovery of M<sub>3</sub> Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary DiseaseElisabetta Armani, Andrea Rizzi, Carmelida Capaldi, et al.
Journal of Medicinal Chemistry|January 10, 2014
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseasesElisabetta Armani, Gabriele Amari, Andrea Rizzi, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Oncogenic Kras <sup>G12D</sup> specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 <sup>+</sup> T cells dependent mannerKrishnan K Mahadevan, Kathleen M McAndrews, Valerie S LeBleu, et al.
Pageof 91